-
Signature
-
By: /s/ Aaron I. Davis, Chief Executive Officer, Boxer Capital, LLC
-
Stock symbol
-
TYRA
-
Transactions as of
-
Feb 6, 2024
-
Transactions value $
-
$9,999,978
-
Form type
-
4
-
Date filed
-
2/8/2024, 05:09 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
TYRA |
Common Stock |
Award |
$825K |
+63.4K |
+281.49% |
$13.01 |
85.9K |
Feb 6, 2024 |
See Footnote |
F1 |
holding |
TYRA |
Common Stock |
|
|
|
|
|
6.45M |
Feb 6, 2024 |
Direct |
F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
TYRA |
Warrant (right to purchase) |
Award |
$9.17M |
+705K |
|
$13.01 |
705K |
Feb 6, 2024 |
Common Stock |
705K |
$0.00 |
Direct |
F2, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
The reporting persons may be deemed members of a group that beneficially owns more than 10% of the outstanding shares of the outstanding shares of Tyra Biosciences, Inc. common stock ("Common Stock"), par value $0.0001 per share